Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 14:15:17 UTC |
---|
Update Date | 2021-09-26 23:09:05 UTC |
---|
HMDB ID | HMDB0254804 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione |
---|
Description | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom). Based on a literature review very few articles have been published on 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione. This compound has been identified in human blood as reported by (PMID: 31557052 ). 2-[[5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN(C)CCCC1=CC(NC2=NC=C3CC(=S)NC4=C(C=CC(=C4)C(F)(F)F)C3=N2)=C(C)N=C1 InChI=1S/C24H25F3N6S/c1-14-19(9-15(12-28-14)5-4-8-33(2)3)31-23-29-13-16-10-21(34)30-20-11-17(24(25,26)27)6-7-18(20)22(16)32-23/h6-7,9,11-13H,4-5,8,10H2,1-3H3,(H,30,34)(H,29,31,32) |
---|
Synonyms | Value | Source |
---|
9-Trifluoromethyl-2-((5-(3-(dimethylamino)propyl)-2-methylpyridin-3-yl)amino)-5,7-dihydro-6H-pyrimido(5,4-D)(1)benzazepine-6-thione | HMDB |
|
---|
Chemical Formula | C24H25F3N6S |
---|
Average Molecular Weight | 486.56 |
---|
Monoisotopic Molecular Weight | 486.181350492 |
---|
IUPAC Name | 4-({5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl}amino)-13-(trifluoromethyl)-3,5,10-triazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2,4,6,12,14-hexaene-9-thione |
---|
Traditional Name | 4-({5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl}amino)-13-(trifluoromethyl)-3,5,10-triazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2,4,6,12,14-hexaene-9-thione |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN(C)CCCC1=CC(NC2=NC=C3CC(=S)NC4=C(C=CC(=C4)C(F)(F)F)C3=N2)=C(C)N=C1 |
---|
InChI Identifier | InChI=1S/C24H25F3N6S/c1-14-19(9-15(12-28-14)5-4-8-33(2)3)31-23-29-13-16-10-21(34)30-20-11-17(24(25,26)27)6-7-18(20)22(16)32-23/h6-7,9,11-13H,4-5,8,10H2,1-3H3,(H,30,34)(H,29,31,32) |
---|
InChI Key | CODBZFJPKJDNDT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzazepines |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzazepines |
---|
Alternative Parents | |
---|
Substituents | - Benzazepine
- Aminopyridine
- Methylpyridine
- Aminopyrimidine
- Azepine
- Aralkylamine
- Pyridine
- Pyrimidine
- Benzenoid
- Heteroaromatic compound
- Thiolactam
- Tertiary amine
- Tertiary aliphatic amine
- Azacycle
- Thiocarbonyl group
- Alkyl halide
- Alkyl fluoride
- Organosulfur compound
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)NC3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C | 3609.1 | Semi standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)NC3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C | 3561.6 | Standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)NC3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C | 4905.8 | Standard polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TMS,isomer #2 | CC1=NC=C(CCCN(C)C)C=C1NC1=NC=C2CC(=S)N([Si](C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1 | 3585.3 | Semi standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TMS,isomer #2 | CC1=NC=C(CCCN(C)C)C=C1NC1=NC=C2CC(=S)N([Si](C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1 | 3602.9 | Standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TMS,isomer #2 | CC1=NC=C(CCCN(C)C)C=C1NC1=NC=C2CC(=S)N([Si](C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1 | 5077.3 | Standard polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,2TMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)N([Si](C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C | 3478.2 | Semi standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,2TMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)N([Si](C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C | 3626.3 | Standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,2TMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)N([Si](C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C | 4361.3 | Standard polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TBDMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)NC3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C(C)(C)C | 3753.5 | Semi standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TBDMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)NC3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C(C)(C)C | 3760.1 | Standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TBDMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)NC3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C(C)(C)C | 4899.2 | Standard polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TBDMS,isomer #2 | CC1=NC=C(CCCN(C)C)C=C1NC1=NC=C2CC(=S)N([Si](C)(C)C(C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1 | 3765.7 | Semi standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TBDMS,isomer #2 | CC1=NC=C(CCCN(C)C)C=C1NC1=NC=C2CC(=S)N([Si](C)(C)C(C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1 | 3802.9 | Standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,1TBDMS,isomer #2 | CC1=NC=C(CCCN(C)C)C=C1NC1=NC=C2CC(=S)N([Si](C)(C)C(C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1 | 5074.6 | Standard polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,2TBDMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)N([Si](C)(C)C(C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C(C)(C)C | 3806.3 | Semi standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,2TBDMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)N([Si](C)(C)C(C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C(C)(C)C | 3998.2 | Standard non polar | 33892256 | 2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione,2TBDMS,isomer #1 | CC1=NC=C(CCCN(C)C)C=C1N(C1=NC=C2CC(=S)N([Si](C)(C)C(C)(C)C)C3=CC(C(F)(F)F)=CC=C3C2=N1)[Si](C)(C)C(C)(C)C | 4394.9 | Standard polar | 33892256 |
| Show more...
---|